FDA approves twice-yearly injectable lenacapavir for PrEP
By Jessica Bloome, MD, MPH On June 18, the FDA approved the latest medication for HIV prevention – long-acting injectable lenacapavir (LEN), a subcutaneous injection administered every 6…
More...